Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease
Advances in Pharmacology · 2023 · 257-281
DOI: 10.1016/bs.apha.2022.12.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Pharmacology, 2023. Verfasst von Matthew Spite und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospi…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States. Electronic…
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, United States. Electronic address: fredmag@amc.edu.
Förderung
- National Institutes of Health
Zitieren
APA
Spite, M., & Fredman, G. (2023). Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease. Advances in Pharmacology, 257-281. https://doi.org/10.1016/bs.apha.2022.12.005
Vancouver
Spite M, Fredman G. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease. Advances in Pharmacology. 2023:257-281. doi:10.1016/bs.apha.2022.12.005
BibTeX
@article{Spite2023,
author = {Spite, Matthew and Fredman, Gabrielle},
title = {Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease},
journal = {Advances in Pharmacology},
year = {2023},
pages = {257--281},
doi = {10.1016/bs.apha.2022.12.005}
}
EUVIMED